Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sommer

Showing results (231-240 of 279) with videos related to

Pageof 28
Sort By:
Schizophrenia Research|March 12, 2021
The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trialLyliana G Nasib, Shiral S Gangadin, Inge Winter-van Rossum, et al.
Schizophrenia Bulletin|June 18, 2014
Psychological therapies for auditory hallucinations (voices): current status and key directions for future researchNeil Thomas, Mark Hayward, Emmanuelle Peters, et al.
JAMA Psychiatry|October 1, 2025
Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical TrialIris E Sommer, Franciska de Beer, Shiral Gangadin, et al.
Journal of Pediatric Urology|June 14, 2024
Size matters: Total testicular volume predicts sperm count in Tanner V varicocele patientsAlexander H Fang, Israel Franco, Joseph M Pizzuti, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Schizophrenia Bulletin Open|August 15, 2024
Real-Time Symptom Capture of Hallucinations in Schizophrenia with fMRI: Absence of Duration-Dependent ActivityKaranvir Gill, Chantal Percival, Meighen Roes, et al.
NPJ Schizophrenia|June 24, 2016
Early interventions in risk groups for schizophrenia: what are we waiting for?Iris E Sommer, Carrie E Bearden, Edwin van Dellen, et al.
Neuroscience Bulletin|July 24, 2020
Joint Multi-modal Parcellation of the Human Striatum: Functions and Clinical RelevanceXiaojin Liu, Simon B Eickhoff, Felix Hoffstaedter, et al.
ACS Pharmacology & Translational Science|April 17, 2020
The European Research Network on Signal Transduction (ERNEST): Toward a Multidimensional Holistic Understanding of G Protein-Coupled Receptor SignalingMartha E Sommer, Jana Selent, Jens Carlsson, et al.
Pageof 28

Showing results (231-240 of 279) with videos related to

Sort By:
Pageof 28
Schizophrenia Research|March 12, 2021
The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trialLyliana G Nasib, Shiral S Gangadin, Inge Winter-van Rossum, et al.
Schizophrenia Bulletin|June 18, 2014
Psychological therapies for auditory hallucinations (voices): current status and key directions for future researchNeil Thomas, Mark Hayward, Emmanuelle Peters, et al.
JAMA Psychiatry|October 1, 2025
Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical TrialIris E Sommer, Franciska de Beer, Shiral Gangadin, et al.
Journal of Pediatric Urology|June 14, 2024
Size matters: Total testicular volume predicts sperm count in Tanner V varicocele patientsAlexander H Fang, Israel Franco, Joseph M Pizzuti, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Schizophrenia Bulletin Open|August 15, 2024
Real-Time Symptom Capture of Hallucinations in Schizophrenia with fMRI: Absence of Duration-Dependent ActivityKaranvir Gill, Chantal Percival, Meighen Roes, et al.
NPJ Schizophrenia|June 24, 2016
Early interventions in risk groups for schizophrenia: what are we waiting for?Iris E Sommer, Carrie E Bearden, Edwin van Dellen, et al.
Neuroscience Bulletin|July 24, 2020
Joint Multi-modal Parcellation of the Human Striatum: Functions and Clinical RelevanceXiaojin Liu, Simon B Eickhoff, Felix Hoffstaedter, et al.
ACS Pharmacology & Translational Science|April 17, 2020
The European Research Network on Signal Transduction (ERNEST): Toward a Multidimensional Holistic Understanding of G Protein-Coupled Receptor SignalingMartha E Sommer, Jana Selent, Jens Carlsson, et al.
Pageof 28